Cite
HARVARD Citation
Machiels, J. et al. (2020). Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients. Journal for immunotherapy of cancer. 8 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Machiels, J. et al. (2020). Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients. Journal for immunotherapy of cancer. 8 (2), p. . [Online].